People with a migration background have experienced a high burden of SARS-CoV-2 infection and severe disease progression. Promoting vaccination uptake among these groups is crucial, however, in many areas, uptake has remained unevaluated. This study explored the association between migration background and first-...
Sophie L. Campman, M. D. Lasheras Carbajo, Anders Boyd et al.· BMC Public Health· 0 citations
Vaccination showed little or no association with ICU admission, but was associated with a one-quarter reduction in IHD among hospitalized older adults, reinforcing its benefits against fatal in-hospital outcomes.
Diogo F. P. Marques, Angela M. C. Rose, S. Monge et al.· Expert Review of Vaccines· 0 citations
Adapted XBB.1.1.5 vaccine provided moderate protection within 120 days after vaccination against severe COVID-19 outcomes among ICPs aged ≥18 years during a period with BA.2.1 replacing the XBB.1.5 variant.
A. Blake, J. Humphreys, K. Olson et al.· Expert Review of Vaccines· 0 citations
The 2023 and 2024 autumn vaccination campaigns resulted in substantially different numbers of averted COVID-19-related hospitalisations and deaths among older adults, with fewer events averted in 2024, highlighting the impact of vaccination programmes depends not only on VC and VE but also on alignment between vaccinat...
Y. Mansiaux, A. Blake, N. Nicolay et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.